BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12709053)

  • 1. A steady-state competition model describes the modulating effects of thrombomodulin on thrombin inhibition by plasminogen activator inhibitor-1 in the absence and presence of vitronectin.
    Dekker RJ; Pannekoek H; Horrevoets AJ
    Eur J Biochem; 2003 May; 270(9):1942-51. PubMed ID: 12709053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of exosites 1 and 2 in thrombin reaction with plasminogen activator inhibitor-1 in the absence and presence of cofactors.
    Rezaie AR
    Biochemistry; 1999 Nov; 38(44):14592-9. PubMed ID: 10545182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop.
    Dekker RJ; Eichinger A; Stoop AA; Bode W; Pannekoek H; Horrevoets AJ
    J Mol Biol; 1999 Oct; 293(3):613-27. PubMed ID: 10543954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The composition of complexes between plasminogen activator inhibitor 1, vitronectin and either thrombin or tissue-type plasminogen activator.
    van Meijer M; Stoop A; Smilde A; Preissner KT; van Zonneveld AJ; Pannekoek H
    Thromb Haemost; 1997 Mar; 77(3):516-21. PubMed ID: 9066004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen activator inhibitor-1 and vitronectin promote the cellular clearance of thrombin by low density lipoprotein receptor-related proteins 1 and 2.
    Stefansson S; Lawrence DA; Argraves WS
    J Biol Chem; 1996 Apr; 271(14):8215-20. PubMed ID: 8626514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of plasminogen activator inhibitor type-1 (PAI-1) with vitronectin.
    Arroyo De Prada N; Schroeck F; Sinner EK; Muehlenweg B; Twellmeyer J; Sperl S; Wilhelm OG; Schmitt M; Magdolen V
    Eur J Biochem; 2002 Jan; 269(1):184-92. PubMed ID: 11784312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vimentin exposed on activated platelets and platelet microparticles localizes vitronectin and plasminogen activator inhibitor complexes on their surface.
    Podor TJ; Singh D; Chindemi P; Foulon DM; McKelvie R; Weitz JI; Austin R; Boudreau G; Davies R
    J Biol Chem; 2002 Mar; 277(9):7529-39. PubMed ID: 11744725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Less pronounced enhancement of thrombin-dependent inactivation of plasminogen activator inhibitor type 1 by low molecular weight heparin compared with unfractionated heparin.
    Nakamura R; Umemura K; Hashimmoto H; Urano T
    Thromb Haemost; 2006 Apr; 95(4):637-42. PubMed ID: 16601834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the binding of different conformational forms of plasminogen activator inhibitor-1 to vitronectin. Implications for the regulation of pericellular proteolysis.
    Lawrence DA; Palaniappan S; Stefansson S; Olson ST; Francis-Chmura AM; Shore JD; Ginsburg D
    J Biol Chem; 1997 Mar; 272(12):7676-80. PubMed ID: 9065424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of plasminogen activator inhibitor type-1 (PAI-1) with vitronectin (Vn): mapping the binding sites on PAI-1 and Vn.
    Schroeck F; Arroyo de Prada N; Sperl S; Schmitt M; Viktor M
    Biol Chem; 2002; 383(7-8):1143-9. PubMed ID: 12437099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of a plasminogen activator inhibitor-1 variant without measurable affinity to vitronectin but otherwise normal.
    Jensen JK; Durand MK; Skeldal S; Dupont DM; Bødker JS; Wind T; Andreasen PA
    FEBS Lett; 2004 Jan; 556(1-3):175-9. PubMed ID: 14706846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The suicide substrate reaction between plasminogen activator inhibitor 1 and thrombin is regulated by the cofactors vitronectin and heparin.
    van Meijer M; Smilde A; Tans G; Nesheim ME; Pannekoek H; Horrevoets AJ
    Blood; 1997 Sep; 90(5):1874-82. PubMed ID: 9292520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activator inhibitor 1 and vitronectin protect against stenosis in a murine carotid artery ligation model.
    de Waard V; Arkenbout EK; Carmeliet P; Lindner V; Pannekoek H
    Arterioscler Thromb Vasc Biol; 2002 Dec; 22(12):1978-83. PubMed ID: 12482822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of inactivation of alpha-thrombin by plasminogen activator inhibitor-1. Comparison of the effects of native and urea-treated forms of vitronectin.
    Naski MC; Lawrence DA; Mosher DF; Podor TJ; Ginsburg D
    J Biol Chem; 1993 Jun; 268(17):12367-72. PubMed ID: 7685341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic analysis of integrin-dependent cell adhesion on vitronectin--the inhibitory potential of plasminogen activator inhibitor-1 and RGD peptides.
    Germer M; Kanse SM; Kirkegaard T; Kjøller L; Felding-Habermann B; Goodman S; Preissner KT
    Eur J Biochem; 1998 May; 253(3):669-74. PubMed ID: 9654064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective screening of a large phage display library of plasminogen activator inhibitor 1 mutants to localize interaction sites with either thrombin or the variable region 1 of tissue-type plasminogen activator.
    van Meijer M; Roelofs Y; Neels J; Horrevoets AJ; van Zonneveld AJ; Pannekoek H
    J Biol Chem; 1996 Mar; 271(13):7423-8. PubMed ID: 8631768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin and the thrombin-thrombomodulin complex interaction with plasminogen activator inhibitor type-1.
    Madden RM; Levin EG; Marlar RA
    Blood Coagul Fibrinolysis; 1991 Jun; 2(3):471-6. PubMed ID: 1657227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute phase protein alpha 1-acid glycoprotein interacts with plasminogen activator inhibitor type 1 and stabilizes its inhibitory activity.
    Boncela J; Papiewska I; Fijalkowska I; Walkowiak B; Cierniewski CS
    J Biol Chem; 2001 Sep; 276(38):35305-11. PubMed ID: 11418606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin neutralizes plasminogen activator inhibitor 1 (PAI-1) that is complexed with vitronectin in the endothelial cell matrix.
    Ehrlich HJ; Gebbink RK; Preissner KT; Keijer J; Esmon NL; Mertens K; Pannekoek H
    J Cell Biol; 1991 Dec; 115(6):1773-81. PubMed ID: 1721912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cluster of basic amino acids in vitronectin contributes to its binding of plasminogen activator inhibitor-1: evidence from thrombin-, elastase- and plasmin-cleaved vitronectins and anti-peptide antibodies.
    Gechtman Z; Belleli A; Lechpammer S; Shaltiel S
    Biochem J; 1997 Jul; 325 ( Pt 2)(Pt 2):339-49. PubMed ID: 9230112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.